MYX 2.39% $4.50 mayne pharma group limited

Ann: MYX announces patent lawsuit against Sun Pharmaceutical, page-18

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,136 Posts.
    lightbulb Created with Sketch. 546
    and the company spent over extra US$20m expense/per year, immediately after the acquisition, to support the products but mainly on IMVEXXY.
    Annovera's patent expiring is approaching.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.